AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 49 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $11,210,000 | +49.0% | 740,882 | -26.2% | 0.01% | +75.0% |
| Q2 2022 | $7,526,000 | +191.5% | 1,003,443 | +253.7% | 0.00% | +300.0% |
| Q1 2022 | $2,582,000 | +20.3% | 283,699 | -7.2% | 0.00% | 0.0% |
| Q4 2021 | $2,147,000 | -66.9% | 305,784 | -46.3% | 0.00% | -66.7% |
| Q3 2021 | $6,491,000 | -37.2% | 569,448 | -11.8% | 0.00% | -40.0% |
| Q2 2021 | $10,338,000 | -17.6% | 645,688 | -8.1% | 0.01% | -28.6% |
| Q1 2021 | $12,553,000 | +156.8% | 702,413 | +94.1% | 0.01% | +133.3% |
| Q4 2020 | $4,888,000 | +53.1% | 361,813 | +33.4% | 0.00% | +50.0% |
| Q3 2020 | $3,193,000 | +89.2% | 271,292 | +137.2% | 0.00% | +100.0% |
| Q2 2020 | $1,688,000 | +357.5% | 114,395 | +318.1% | 0.00% | – |
| Q1 2020 | $369,000 | -32.4% | 27,359 | +20.7% | 0.00% | – |
| Q4 2019 | $546,000 | +9.9% | 22,659 | -12.6% | 0.00% | – |
| Q3 2019 | $497,000 | -89.8% | 25,928 | -84.3% | 0.00% | -100.0% |
| Q2 2019 | $4,869,000 | +37.0% | 164,848 | +120.2% | 0.00% | +50.0% |
| Q1 2019 | $3,555,000 | +152.1% | 74,876 | +91.5% | 0.00% | +100.0% |
| Q4 2018 | $1,410,000 | -87.2% | 39,095 | -78.1% | 0.00% | -66.7% |
| Q3 2018 | $10,974,000 | -57.6% | 178,334 | -53.4% | 0.00% | -57.1% |
| Q2 2018 | $25,869,000 | +632.8% | 383,006 | +488.1% | 0.01% | +250.0% |
| Q1 2018 | $3,530,000 | -33.1% | 65,124 | -26.3% | 0.00% | -33.3% |
| Q4 2017 | $5,277,000 | +11.3% | 88,337 | -9.5% | 0.00% | 0.0% |
| Q3 2017 | $4,743,000 | -78.5% | 97,650 | -76.7% | 0.00% | -81.2% |
| Q2 2017 | $22,063,000 | -29.7% | 419,878 | -39.3% | 0.02% | -30.4% |
| Q1 2017 | $31,387,000 | +9.4% | 692,159 | -8.7% | 0.02% | 0.0% |
| Q4 2016 | $28,694,000 | +10258.8% | 758,142 | +10177.1% | 0.02% | – |
| Q3 2016 | $277,000 | +89.7% | 7,377 | -11.9% | 0.00% | – |
| Q2 2016 | $146,000 | +46.0% | 8,371 | +0.3% | 0.00% | – |
| Q1 2016 | $100,000 | -90.2% | 8,344 | -80.1% | 0.00% | -100.0% |
| Q4 2015 | $1,019,000 | +38.8% | 41,919 | +1.0% | 0.00% | 0.0% |
| Q3 2015 | $734,000 | +235.2% | 41,498 | +232.0% | 0.00% | – |
| Q2 2015 | $219,000 | -90.1% | 12,499 | -82.3% | 0.00% | -100.0% |
| Q1 2015 | $2,212,000 | +230.6% | 70,646 | +207.2% | 0.00% | – |
| Q4 2014 | $669,000 | +215.6% | 22,994 | +124.0% | 0.00% | – |
| Q3 2014 | $212,000 | +33.3% | 10,263 | +59.1% | 0.00% | – |
| Q2 2014 | $159,000 | +8.9% | 6,451 | -6.7% | 0.00% | – |
| Q1 2014 | $146,000 | -73.7% | 6,913 | -77.7% | 0.00% | – |
| Q4 2013 | $556,000 | – | 31,046 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|